Table 2.
Domain | Measure | N | Range | Sample Mean (SD) |
Adult cancer patients† Mean (SD) |
Metastatic breast cancer‡ Mean (SD) |
---|---|---|---|---|---|---|
Health-related quality of life | Functional Assessment of Cancer Therapy-General | 223 | 25–107 | 65.5 (16.4) | 79.3 (17.0) | 81.9 (14.3) |
Physical well-being | 224 | 3–28 | 18.4 (6.1) | 21.0 (6.0) | ||
Social/family well-being | 224 | 5–28 | 17.8 (5.4) | 22.0 (5.3) | ||
Emotional well-being | 223 | 0–23 | 13.1 (5.0) | 18.1 (4.6) | ||
Functional well-being | 223 | 2–28 | 16.1 (5.4) | 18.2 (6.6) | ||
Anxiety symptom severity | PROMIS Anxiety* | 210 | 37–83 | 56.0 (9.8) | ||
Depression symptom severity | PROMIS Depression* | 210 | 38–81 | 56.0 (8.3) | ||
Parenting concerns | Parenting Concerns Questionnaire | 211 | 1–5 | 2.2 (0.7) | ||
Practical concerns | 211 | 1–5 | 2.3 (0.9) | |||
Emotional concerns | 210 | 1–5 | 2.2 (0.9) | |||
Concerns about co-parent | 206 | 1–5 | 2.1 (1.1) |
T score normed to population
Adult cancer patient sample, all disease types, n=4912; Pearman et al, Ambulatory Cancer and US General Population References Values and Cutoff Scores for the Functional Assessment of Cancer Therapy. Cancer 2014;(120), p2906.20
Adult metastatic breast cancer patient sample, n=187; Pearman et al, Ambulatory Cancer and US General Population References Values and Cutoff Scores for the Functional Assessment of Cancer Therapy. Cancer 2014;(120), online supplement.20
Abbreviations: PROMIS=Patient-Reported Outcomes Measurement Information System (range 0–100, higher scores indicate more symptoms, 50=US general population mean);